Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 4 of 5
Topical Formulation
Mometasone Furoate 0.3%w/w + Fusidic Acid 2%w/w is a topical formulation formulated with Mometasone Furoate 0.3%w/w + Fusidic Acid 2%w/w. The listed active ingredient profile is Mometasone Furoate w/w; Fusidic Acid w/w, placing the product in the topical
Cream
Mometasone Furoate IP 0.1% + Fusidic Acid IP 2%w/w Cream is a cream formulated with Mometasone Furoate IP 0.1% + Fusidic Acid IP 2%w/w. The listed active ingredient profile is Mometasone Furoate %; Fusidic Acid w/w, placing the product in the topical anti
Cream
Mometasone Furoate IP 0.1%w/w + Terbinafine HCL BP 1%w/w Cream is a cream formulated with Mometasone Furoate IP 0.1%w/w + Terbinafine HCL BP 1%w/w. The listed active ingredient profile is Mometasone Furoate w/w; Terbinafine HCL w/w, placing the product in
Topical Formulation
Mupirocin 2%w/w + Methyl Paraben 0.16%w/w + Propyl Paraben 0.33./w/w is a topical formulation formulated with Mupirocin 2%w/w + Methyl Paraben 0.16%w/w + Propyl Paraben 0.33./w/w. The listed active ingredient profile is Mupirocin w/w; Methyl Paraben w/w;
Ointment
Mupirocin lp 2%w/w + Methyl Parabe IP 0.16%w/w + Propyl Paraben IP 0.33%w/w Ointment is a ointment formulated with Mupirocin lp 2%w/w + Methyl Parabe IP 0.16%w/w + Propyl Paraben IP 0.33%w/w. The listed active ingredient profile is Mupirocin lp w/w; Methy
Topical Formulation
Nadifloxacin 10 mg is a topical formulation formulated with Nadifloxacin 10 mg. The listed active ingredient profile is Nadifloxacin, placing the product in the topical antibacterial / dermatology category. The formulation contains topical antibacterial i
Topical Formulation
Onoxacin 0.757%w/w + Ornidazole 2%w/w + traCongzole 1%w/w + clobetasol Propionate 0.05/%ve/w + Methyl Paraben 0.20%w/w*Propylparaben 0.02%%w/w is a topical formulation formulated with Onoxacin 0.757%w/w + Ornidazole 2%w/w + traCongzole 1%w/w + clobetasol
Topical Formulation
Permethrin 5%w/w is a topical formulation formulated with Permethrin 5%w/w. The listed active ingredient profile is Permethrin w/w, placing the product in the topical antiparasitic category. The formulation contains a topical antiparasitic medicine used f
Topical Formulation
Permethrin 50 mg + Formaldehyde Solution 1 mg is a topical formulation formulated with Permethrin 50 mg + Formaldehyde Solution 1 mg. The listed active ingredient profile is Permethrin; Formaldehyde Solution, placing the product in the topical antiparasit
Topical Formulation
Potassium Nitrate 5% w/w, + Sodium Monofluorophosphate 0.7% + Triclosan 0.5%w/w is a topical formulation formulated with Potassium Nitrate 5% w/w, + Sodium Monofluorophosphate 0.7% + Triclosan 0.5%w/w. The listed active ingredient profile is Potassium Nit
Topical Formulation
Povidone-Iodine 0.5%w/w is a topical formulation formulated with Povidone-Iodine 0.5%w/w. The listed active ingredient profile is Povidone-Iodine w/w, placing the product in the antiseptic / wound care category. The formulation contains antiseptic and/or
Topical Formulation
Povidone-Iodine 10%w/w*Metronidazole 2%w/w is a topical formulation formulated with Povidone-Iodine 10%w/w*Metronidazole 2%w/w. The listed active ingredient profile is Povidone-Iodine w/w*Metronidazole w/w, placing the product in the antiseptic / wound ca
Topical Formulation
Povidone-Iodine 5%w/w + Metronidazole 1 %w/w + Aloe Vera 1.57%w/w is a topical formulation formulated with Povidone-Iodine 5%w/w + Metronidazole 1 %w/w + Aloe Vera 1.57%w/w. The listed active ingredient profile is Povidone-Iodine w/w; Metronidazole w/w; A
Ointment
Povidone-Iodine IP 10%w/w + Metronidazole IP 27%w/w Ointment is a ointment formulated with Povidone-Iodine IP 10%w/w + Metronidazole IP 27%w/w. The listed active ingredient profile is Povidone-Iodine w/w; Metronidazole w/w, placing the product in the anti
Ointment
Povidone-Iodine IP 5%w/w + (Availabe lodine 0.5%w/w) Metronidazole P 1%w/w + Aloe Vera 1.595w/w Ointment is a ointment formulated with Povidone-Iodine IP 5%w/w + (Availabe lodine 0.5%w/w) Metronidazole P 1%w/w + Aloe Vera 1.595w/w. The listed active ingre
Topical Formulation
Salicylic Acid 6%w/w is a topical formulation formulated with Salicylic Acid 6%w/w. The listed active ingredient profile is Salicylic Acid w/w, placing the product in the keratolytic / dermatology category. The formulation contains keratolytic ingredients
Topical Formulation
Sertaconazole Nitrate 2% w/w Benzyl Alcohol 1%w/w is a topical formulation formulated with Sertaconazole Nitrate 2% w/w Benzyl Alcohol 1%w/w. The listed active ingredient profile is Sertaconazole Nitrate % w/w Benzyl Alcohol w/w, placing the product in th
Cream
Sertaconazole Nitrate IP 2%w/w + Benzyl Alcohol 1%w/w Cream is a cream formulated with Sertaconazole Nitrate IP 2%w/w + Benzyl Alcohol 1%w/w. The listed active ingredient profile is Sertaconazole Nitrate w/w; Benzyl Alcohol w/w, placing the product in the
Topical Formulation
Silver Sulphadiazine 1.0%w/w is a topical formulation formulated with Silver Sulphadiazine 1.0%w/w. The listed active ingredient profile is Silver Sulphadiazine w/w, placing the product in the antiseptic / wound care category. The formulation contains ant
Topical Formulation
Sodium Fluride 0.2Tw/w + Triclosan 0.3%w/w is a topical formulation formulated with Sodium Fluride 0.2Tw/w + Triclosan 0.3%w/w. The listed active ingredient profile is Sodium Fluride .2Tw/w; Triclosan w/w, placing the product in the topical dermatology ca
Gel
Sodium MonoFluorophosphate USP 0.38%w/w Gel is a gel formulated with Sodium MonoFluorophosphate USP 0.38%w/w. The listed active ingredient profile is Sodium MonoFluorophosphate w/w, placing the product in the dental / oral care category. The formulation c
Topical Formulation
Sodium Monoflurophosphate 0.387%w/w is a topical formulation formulated with Sodium Monoflurophosphate 0.387%w/w. The listed active ingredient profile is Sodium Monoflurophosphate w/w, placing the product in the topical dermatology category. The formulati
Topical Formulation
Sucralfate 70mg + Metronidazole 10mg + Povidone-Iodine 50mg is a topical formulation formulated with Sucralfate 70mg + Metronidazole 10mg + Povidone-Iodine 50mg. The listed active ingredient profile is Sucralfate; Metronidazole; Povidone-Iodine, placing t
Ointment
Sucralfate USP 70 mg + Metronidazole IP 10 mg + Povidone-Iodine 50 mg Ointment is a ointment formulated with Sucralfate USP 70 mg + Metronidazole IP 10 mg + Povidone-Iodine 50 mg. The listed active ingredient profile is Sucralfate; Metronidazole; Povidone
Topical Formulation
Tacrolimus 0.03%w/w is a topical formulation formulated with Tacrolimus 0.03%w/w. The listed active ingredient profile is Tacrolimus w/w, placing the product in the topical anti-inflammatory / dermatology category. The formulation contains topical anti-in
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
